PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Purple Biotech Ltd (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Purple Biotech Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Purple Biotech Reports Third Quarter 2024 Financial Results
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Form 6-K PURPLE BIOTECH LTD. For: Nov 15
Form SC 13G/A PURPLE BIOTECH LTD. Filed by: ARMISTICE CAPITAL, LLC
Form 6-K PURPLE BIOTECH LTD. For: Nov 04
Form 6-K PURPLE BIOTECH LTD. For: Oct 25
Form 6-K PURPLE BIOTECH LTD. For: Oct 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.